Patents by Inventor Tage Thorstensen
Tage Thorstensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240041976Abstract: The invention relates to antibacterial compositions comprising micrococcin P1 and at least one additional antibacterial agent, which is preferably a bacteriocin or an antibiotic. The compositions may be used as an antibacterial, particularly for preventing or treating a bacterial infection.Type: ApplicationFiled: September 14, 2021Publication date: February 8, 2024Applicants: Norwegian University of Life Sciences, Norwegian Institute of Bioeconomy ResearchInventors: Dzung DIEP, Kirill OVCHINNIKOV, Christian KRANJEC, Tage THORSTENSEN
-
Patent number: 11648289Abstract: The present invention provides a method of killing, damaging or preventing the replication of bacteria comprising administering or applying a bacteriocin to said bacteria, wherein said bacteriocin is a peptide comprising the amino acid sequence MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC and related sequences, wherein the bacteria is selected from E. faecium, E. faecalis, E. hirae, S. pseudointermedius and/or S. hemolyticus; and/or in said method said bacteria are subjected to a stress condition. Also provided are related methods and uses such as methods of treatment. Also provided are novel truncation and fusion proteins variants such as MIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA and MKFKFNPTGTIVKKLTQYEINWYKQQYGRYPWERPVA and their use as bacteriocins in various methods and uses.Type: GrantFiled: October 1, 2020Date of Patent: May 16, 2023Assignee: NORWEGIAN UNIVERSITY OF LIFE SCIENCESInventors: Dzung B. Diep, Kirill V. Ovchinnikov, Per E. Kristiansen, Ingolf F. Nes, Tage Thorstensen
-
Publication number: 20210024588Abstract: The present invention provides a method of killing, damaging or preventing the replication of bacteria comprising administering or applying a bacteriocin to said bacteria, wherein said bacteriocin is a peptide comprising the amino acid sequence MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC and related sequences, wherein the bacteria is selected from E. faecium, E. faecalis, E. hirae, S. pseudointermedius and/or S. hemolyticus; and/or in said method said bacteria are subjected to a stress condition. Also provided are related methods and uses such as methods of treatment. Also provided are novel truncation and fusion proteins variants such as MIKKFPNPYTLAAKLTTYEINVVYKQQYGRYPWERPVA and MKFKFNPTGTIVKKLTQYEINVVYKQQYGRYPWERPVA and their use as bacteriocins in various methods and uses.Type: ApplicationFiled: October 1, 2020Publication date: January 28, 2021Applicant: NORWEGIAN UNIVERSITY OF LIFE SCIENCESInventors: Dzung B. DIEP, Kirill V. OVCHINNIKOV, Per E. KRISTIANSEN, Ingolf F. NES, Tage THORSTENSEN
-
Publication number: 20210017236Abstract: The present invention provides a method of killing, damaging or preventing the replication of bacteria comprising administering or applying a bacteriocin to said bacteria, wherein said bacteriocin is a peptide comprising the amino acid sequence MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC and related sequences, wherein the bacteria is selected from E. faecium, E. faecalis, E. hirae, S. pseudointermedius and/or S. hemolyticus; and/or in said method said bacteria are subjected to a stress condition. Also provided are related methods and uses such as methods of treatment. Also provided are novel truncation and fusion proteins variants such as MIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA and MKFKFNPTGTIVKKLTQYEINWYKQQYGRYPWERPVA and their use as bacteriocins in various methods and uses.Type: ApplicationFiled: October 1, 2020Publication date: January 21, 2021Applicant: NORWEGIAN UNIVERSITY OF LIFE SCIENCESInventors: Dzung B. DIEP, Kirill V. OVCHINNIKOV, Per E. KRISTIANSEN, Ingolf F. NES, Tage THORSTENSEN
-
Patent number: 10851139Abstract: The present invention provides a method of killing, damaging or preventing the replication of bacteria comprising administering or applying a bacteriocin to said bacteria, wherein said bacteriocin is a peptide comprising the amino acid sequence MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC and related sequences, wherein the bacteria is selected from E. faecium, E. faecalis. E. hirae, S. pseudointermedius and/or S. hemolyticus; and/or in said method said bacteria are subjected to a stress condition. Also provided are related methods and uses such as methods of treatment. Also provided are novel truncation and fusion proteins variants such as MIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA and MKFKFNPTGTIVKKLTQYEINWYKQQYGRYPWERPVA and their use as bacteriocins in various methods and uses.Type: GrantFiled: December 14, 2017Date of Patent: December 1, 2020Assignee: NORWEGIAN UNIVERSITY OF LIFE SCIENCESInventors: Dzung B. Diep, Kirill V. Ovchinnikov, Per E. Kristiansen, Ingolf F. Nes, Tage Thorstensen
-
Publication number: 20190322705Abstract: The present invention provides a method of killing, damaging or preventing the replication of bacteria comprising administering or applying a bacteriocin to said bacteria, wherein said bacteriocin is a peptide comprising the amino acid sequence MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC and related sequences, wherein the bacteria is selected from E. faecium, E. faecalis. E. hirae, S. pseudointermedius and/or S. hemolyticus; and/or in said method said bacteria are subjected to a stress condition. Also provided are related methods and uses such as methods of treatment. Also provided are novel truncation and fusion proteins variants such as MIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA and MKFKFNPTGTIVKKLTQYEINWYKQQYGRYPWERPVA and their use as bacteriocins in various methods and uses.Type: ApplicationFiled: December 14, 2017Publication date: October 24, 2019Applicant: NORWEGIAN UNIVERSITY OF LIFE SCIENCESInventors: Dzung B. DIEP, Kirill V. OVCHINNIKOV, Per E. KRISTIANSEN, Ingolf F. NES, Tage THORSTENSEN
-
Publication number: 20140148355Abstract: The present invention relates to polypeptides that bind to H3K4 methylated chromatin, and in particular to the use of reagents comprising such polypeptides for epigenetic/epigenomic analysis.Type: ApplicationFiled: March 28, 2012Publication date: May 29, 2014Applicant: UNIVERSITY OF OSLOInventors: Reidunn B. Aalen, Tage Thorstensen, Rein Aasland, Verena Hoppmann